Yet the data from different NSCLC cell lines were unable to give an attribution of the differential effect of ATO to the particular EGFR mutants as the cellular backgrounds other than the EGFR mutations in the different cell lines might vary. Here, EGFR is linked to non-small cell lung carcinoma.